ARCHIVES

FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

White House Announces FDA Initiatives To accelerate Cancer Drug Approval

April 4, 1996

NCI Letter to HCFA Outlines Positions, Offers Glimpse of Tactics

September 27, 1996

Report Urges Enhancement Of Cancer Data Systems.

October 20, 2000

Millers Win Bristol-Myers $25,000 Award

May 19, 1978

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

April 13, 2007

Cancer Programs Close Amid Gridlock

October 4, 2013